Clinical outcomes following intravitreal methotrexate for primary vitreoretinal lymphoma

zu Verbundenen Objekten

Standort
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
2056-9920
Umfang
Online-Ressource
Sprache
Englisch
Anmerkungen
online resource.

Erschienen in
Clinical outcomes following intravitreal methotrexate for primary vitreoretinal lymphoma ; volume:7 ; number:1 ; day:4 ; month:12 ; year:2021 ; pages:1-7 ; date:12.2021
International Journal of Retina and Vitreous ; 7, Heft 1 (4.12.2021), 1-7, 12.2021

Urheber
Anthony, Casey L.
Bavinger, J. Clay
Shantha, Jessica G.
O’Keefe, Ghazala D.
Pearce, William A.
Voloschin, Alfredo
Grossniklaus, Hans E.
Yeh, Steven
Beteiligte Personen und Organisationen
SpringerLink (Online service)

DOI
10.1186/s40942-021-00346-0
URN
urn:nbn:de:101:1-2022020720542247493356
Rechteinformation
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Letzte Aktualisierung
22.08.2025, 07:30 MESZ

Datenpartner

Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Original beim Datenpartner anzeigen

Beteiligte

  • Anthony, Casey L.
  • Bavinger, J. Clay
  • Shantha, Jessica G.
  • O’Keefe, Ghazala D.
  • Pearce, William A.
  • Voloschin, Alfredo
  • Grossniklaus, Hans E.
  • Yeh, Steven
  • SpringerLink (Online service)

Ähnliche Objekte (12)

Retinal changes of primary vitreoretinal lymphoma after intravitreal methotrexate

Retinal changes of primary vitreoretinal lymphoma after intravitreal methotrexate

Reduced frequency of Intravitreal methotrexate injection lowers the risk of Keratopathy in Vitreoretinal lymphoma patients

Reduced frequency of Intravitreal methotrexate injection lowers the risk of Keratopathy in Vitreoretinal lymphoma patients

Longitudinal observation of OCT imaging is a valuable tool to monitor primary vitreoretinal lymphoma treated with intravitreal injections of methotrexate

Longitudinal observation of OCT imaging is a valuable tool to monitor primary vitreoretinal lymphoma treated with intravitreal injections of methotrexate

Primary Vitreoretinal Lymphoma Therapy Monitoring: Significant Vitreous Haze Reduction After Intravitreal Rituximab

Primary Vitreoretinal Lymphoma Therapy Monitoring: Significant Vitreous Haze Reduction After Intravitreal Rituximab

Multimodal diagnostic imaging in primary vitreoretinal lymphoma

Multimodal diagnostic imaging in primary vitreoretinal lymphoma

Vitreoretinal lymphoma followed by systemic diffuse large B cell lymphoma

Vitreoretinal lymphoma followed by systemic diffuse large B cell lymphoma

Resident Vitreoretinal Procedure Volume: Effect of Intravitreal Injections, Region, Program Size, and Vitreoretinal Fellowship and Veterans Affairs Affiliation

Resident Vitreoretinal Procedure Volume: Effect of Intravitreal Injections, Region, Program Size, and Vitreoretinal Fellowship and Veterans Affairs Affiliation

An unusual case report of primary vitreoretinal lymphoma

An unusual case report of primary vitreoretinal lymphoma

Electrophysiological Monitoring of Focal and Entire Retinal Function during Treatment with Intravitreal Methotrexate for Intraocular Lymphoma

Electrophysiological Monitoring of Focal and Entire Retinal Function during Treatment with Intravitreal Methotrexate for Intraocular Lymphoma

Diagnostic efficacy of cell block method for vitreoretinal lymphoma

Diagnostic efficacy of cell block method for vitreoretinal lymphoma

Primary Vitreoretinal Lymphoma Presenting Solely with Asymptomatic Peripheral Drusenoid Lesions

Primary Vitreoretinal Lymphoma Presenting Solely with Asymptomatic Peripheral Drusenoid Lesions

The diagnosis and treatment of primary vitreoretinal lymphoma: a review

The diagnosis and treatment of primary vitreoretinal lymphoma: a review

Verbundene Objekte